X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (96) 96
humans (86) 86
respiratory system (86) 86
male (63) 63
female (62) 62
copd (60) 60
aged (57) 57
middle aged (57) 57
chronic obstructive pulmonary disease (50) 50
obstructive pulmonary-disease (47) 47
lung diseases, obstructive (46) 46
pulmonary disease, chronic obstructive - physiopathology (37) 37
research (27) 27
analysis (24) 24
exercise (24) 24
pulmonary disease, chronic obstructive - drug therapy (24) 24
diseases of the respiratory system (23) 23
care and treatment (22) 22
mortality (22) 22
pulmonary/respiratory (21) 21
asthma (20) 20
comorbidity (20) 20
studies (19) 19
abridged index medicus (18) 18
adult (18) 18
double-blind method (18) 18
inflammation (18) 18
lung diseases (18) 18
severity of illness index (18) 18
physical activity (17) 17
dyspnea (16) 16
respiratory tract diseases (16) 16
risk factors (16) 16
medical research (15) 15
pulmonary disease, chronic obstructive - complications (15) 15
critical care medicine (14) 14
forced expiratory volume (14) 14
pulmonary disease, chronic obstructive - diagnosis (14) 14
patients (13) 13
prospective studies (13) 13
pulmonary and respiratory medicine (13) 13
spirometry (13) 13
standardization (13) 13
treatment outcome (13) 13
lung - physiopathology (12) 12
medicine, experimental (12) 12
original research (12) 12
research article (12) 12
administration, inhalation (11) 11
diagnosis (11) 11
obstructive lung disease (11) 11
pharmacology & pharmacy (11) 11
physical-activity (11) 11
quality-of-life (11) 11
age (10) 10
cardiac & cardiovascular systems (10) 10
cohort studies (10) 10
cross-over studies (10) 10
drug therapy (10) 10
exacerbations (10) 10
international journal of chronic obstructive pulmonary disease (10) 10
pulmonary disease, chronic obstructive - epidemiology (10) 10
clinical trials (9) 9
hyperinflation (9) 9
prevalence (9) 9
quality of life (9) 9
respiratory function tests (9) 9
smoking (9) 9
systemic inflammation (9) 9
tiotropium (9) 9
biomarkers (8) 8
case-control studies (8) 8
comorbidities (8) 8
germany (8) 8
gold (8) 8
health aspects (8) 8
health status (8) 8
heart (8) 8
lung-function (8) 8
medical education (8) 8
medicine (8) 8
physical fitness (8) 8
population (8) 8
respiratory agents (8) 8
risk (8) 8
sputum (8) 8
airway inflammation (7) 7
airway management (7) 7
bronchodilator agents - administration & dosage (7) 7
complications and side effects (7) 7
corticosteroids (7) 7
cross-sectional studies (7) 7
drug therapy, combination (7) 7
exercise tolerance (7) 7
forced expiratory volume - physiology (7) 7
internal medicine (7) 7
lung function (7) 7
medicine, general & internal (7) 7
pulmonary disease, chronic obstructive - blood (7) 7
regression analysis (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10082, pp. 1931 - 1940
Summary Chronic obstructive pulmonary disease (COPD) kills more than 3 million people worldwide every year. Despite progress in the treatment of symptoms and... 
Internal Medicine | INHALED FLUTICASONE FUROATE | LUNG-VOLUME REDUCTION | AIR-FLOW LIMITATION | SMOKING-CESSATION | MEDICINE, GENERAL & INTERNAL | CLINICAL-TRIAL | DOUBLE-BLIND | PHYSICAL-ACTIVITY | RANDOMIZED CONTROLLED-TRIAL | PLACEBO-CONTROLLED TRIAL | RESPIRATORY SOCIETY STATEMENT | Pulmonary Disease, Chronic Obstructive - therapy | Pulmonary Disease, Chronic Obstructive - physiopathology | Pulmonary Disease, Chronic Obstructive - etiology | Humans | Development and progression | Lung diseases, Obstructive | Exercise | Research institutes | Smoking | Comorbidity | Mortality | Germany | Heart | Corticoids | Cooking | Income | Tobacco smoking | Smoke | Biomass | Glucose | Epidemiology | Risk factors | Pollution | Mathematical analysis | Chronic obstructive pulmonary disease | Corticosteroids | Medical treatment | Abnormalities | Indoor environments | Metabolism | Ablation | Asthma | Pathology | Gases | Ventilation | Death | Adults | Cardiovascular diseases | Indoor air pollution | Surgical implants | Destruction | Medical services | Clinical trials | Congestive heart failure | Occupational exposure | Fuels | Respiratory tract | Bronchitis | Alveoli | Heart diseases | Age | Oxygen | Diabetes mellitus | Lung diseases | Health risks | Particulates | Cigarette smoking | Coronary artery disease | Inhalation | Air flow | Antibiotics | Heating | Air pollution
Journal Article
by Watz, H
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, ISSN 1073-449X, 05/2019, Volume 199, Issue 9, pp. 1047 - 1048
An increasingly studied mechanism over the last decade is the effect of lung hyperinflation on cardiac filling and the associated consequences for exercise... 
RESPIRATORY SYSTEM | LUNG DEFLATION | CRITICAL CARE MEDICINE | Cross-Over Studies | Double-Blind Method | Humans | Lung | Pulmonary Disease, Chronic Obstructive | Indans | Quinolones | Heart | Physical fitness | Exercise | Medical imaging | Lungs | Deflation | Cardiovascular disease | Chronic obstructive pulmonary disease | Blood
Journal Article
The European respiratory journal, ISSN 0903-1936, 10/2017, Volume 50, Issue 4, pp. 1702084 - 1702084
Journal Article
European Respiratory Journal, ISSN 0903-1936, 04/2017, Volume 49, Issue 4, pp. 1700424 - 1700424
Chronic obstructive pulmonary disease (COPD) is defined by partially reversible airflow limitation as a result of either small airway obstruction or loss of... 
MODERATE | PLACEBO | MULTICENTER | EFFICACY | RESPIRATORY SYSTEM | COMPONENTS | TIOTROPIUM | PHYSICAL-ACTIVITY | CROSSOVER | LUNG HYPERINFLATION | COPD | Respiratory tract | Airway management | Acetylcholine receptors (muscarinic) | Lung diseases | Obstructive lung disease | Bronchodilators | Chronic obstructive pulmonary disease | Antagonists | Inhalation
Journal Article
Deutsche Medizinische Wochenschrift, ISSN 0012-0472, 05/2016, Volume 141, Issue 10, pp. 700 - 703
Journal Article
DMW - Deutsche Medizinische Wochenschrift, ISSN 0012-0472, 07/2016, Volume 141, Issue 14, pp. 1002 - 1002
COPD gehört laut statistischem Bundesamt zu den 5 häufigsten Todesursachen in Deutschland. Schlüsselkriterium für die Diagnose ist eine Verengung der Atemwege,... 
Aktuell publiziert
Journal Article
DMW - Deutsche Medizinische Wochenschrift, ISSN 0012-0472, 05/2016, Volume 141, Issue 10, pp. 700 - 703
Zusammenfassung Symptomatische Patienten mit obstruktiver Ventilationsstörung bedürfen einer pneumologischen Differentialdiagnostik. Bei der überwiegenden Zahl... 
Dossier
Journal Article
Klinikarzt, ISSN 0341-2350, 03/2018, Volume 47, Issue 3, p. 55
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9808, pp. 1997 - 2004
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2016, Volume 138, Issue 1, pp. 142 - 149.e8
Background Roflumilast, a selective phosphodiesterase 4 inhibitor, has been shown to provide modest improvements in lung function in patients with... 
Allergy and Immunology | phosphodiesterase 4 inhibitors | roflumilast | montelukast | Asthma | TRIALS | SPUTUM | IMMUNOLOGY | THERAPY | ALLERGY | DRUGS | PHOSPHODIESTERASE-4 INHIBITOR ROFLUMILAST | QUESTIONNAIRE | COPD | Anti-Asthmatic Agents - adverse effects | Spirometry | Acetates - adverse effects | Anti-Asthmatic Agents - therapeutic use | Humans | Middle Aged | Aminopyridines - adverse effects | Male | Cyclopropanes - adverse effects | Quinolines - administration & dosage | Cyclopropanes - therapeutic use | Forced Expiratory Volume | Benzamides - administration & dosage | Benzamides - therapeutic use | Aminopyridines - therapeutic use | Cyclopropanes - administration & dosage | Leukotriene Antagonists - administration & dosage | Aged, 80 and over | Female | Acetates - therapeutic use | Leukocyte Count | Drug Therapy, Combination | Benzamides - adverse effects | Leukotriene Antagonists - adverse effects | Leukotriene Antagonists - therapeutic use | Asthma - diagnosis | Severity of Illness Index | Aminopyridines - administration & dosage | Risk Factors | Treatment Outcome | Asthma - drug therapy | Disease Progression | Acetates - administration & dosage | Aged | Quinolines - therapeutic use | Anti-Asthmatic Agents - administration & dosage | Quinolines - adverse effects | Care and treatment | Research institutes | Analysis | Medical research | Medicine, Experimental | Respiratory agents | Roflumilast | Genotype & phenotype | Neutrophils | Chronic obstructive pulmonary disease | Infections | Bronchitis | Patients | Methods
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2014, Volume 371, Issue 14, pp. 1285 - 1294
Journal Article
Journal Article
Journal Article